ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

H. Lee Moffitt Cancer Center and Research Institute · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
hematological-malignanciesleukemialymphoma
graft versus host disease, gvhd, allogeneic transplant, gvhd prevention, unrelated donors, mismatched unrelated donors, hematological malignancies, leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, aplastic anemia
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 841539
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.